EarliTec Diagnostics Receives FDA 510(k) Clearance for the EarliPoint Evaluation for Autism Spectrum Disorder

• By: Shay Smith Health+Commerce
• July 19th, 2022
• assessment, children, development, diagnostic tool, early diagnosis, early intervention, eye tracking, FDA, research, Summer 2022 Issue, technology
• 2009    0

The EarliPoint Evaluation is the first FDA-cleared tool to assist clinicians in diagnosing and assessing autism in children as young as 16 months old. On June 10th, 2022, EarliTec Diagnostics, Inc. (EarliTec), a digital health company developing novel diagnostic and therapeutic products for...